Shijian Quan
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Navigating thyroid hormone signaling in liver fibrosis: mechanisms and clinical implications.
Journal: Journal of endocrinological investigation
Published: May 09, 2025
Network pharmacology analysis revealed the mechanism and active compounds of jiao tai wan in the treatment of type 2 diabetes mellitus via SRC/PI3K/AKT signaling.
Journal: Journal of ethnopharmacology
Published: August 01, 2024
Evaluation of the effects of three different processing methods of aconite on rat metabolites based on high-coverage pseudotargeted metabolomics.
Journal: Journal of separation science
Published: August 10, 2023
Paeoniflorin, ferulic acid, and atractylenolide III improved LPS-induced neuroinflammation of BV2 microglia cells by enhancing autophagy.
Journal: Journal of pharmacological sciences
Published: February 09, 2023
Berberine Ameliorates Metabolic-Associated Fatty Liver Disease Mediated Metabolism Disorder and Redox Homeostasis by Upregulating Clock Genes: Clock and Bmal1 Expressions.
Journal: Molecules (Basel, Switzerland)
Published: January 18, 2023
The Pseudotargeted Metabolomics Study on the Toxicity of Fuzi Using Ultraperformance Liquid Chromatography Tandem Mass Spectrometry.
Journal: Evidence-based complementary and alternative medicine : eCAM
Published: March 06, 2022
Formononetin Activates the Nrf2/ARE Signaling Pathway Via Sirt1 to Improve Diabetic Renal Fibrosis.
Journal: Frontiers in pharmacology
Published: October 12, 2020
Renoprotective Effect of Formononetin by Suppressing Smad3 Expression in Db/Db Mice.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: July 14, 2020
Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: April 05, 2019
Pharmacokinetic and nephroprotective benefits of using Schisandra chinensis extracts in a cyclosporine A-based immune-suppressive regime.
Journal: Drug design, development and therapy
Published: September 11, 2015
Showing 1-10 of 10
Last Updated: 09/26/2026